ABSTRACT
Mucormycosis is a rare opportunistic fungal infection in renal transplant recipients which is associated with exceedingly high mortality when inadequately treated. Risk factors for this infection include diabetes, neutropaenia and immunosuppression. We report a case of pulmonary mucormycosis in a renal allograft recipient with type 2 diabetes and limited pulmonary reserve. The patient was successfully treated with lobectomy and liposomal amphotericin B with preservation of pulmonary and allograft functions. Early recognition of this infection is warranted before dissemination, which carries a poor prognosis.
Subject(s)
Immunocompromised Host , Kidney Transplantation/immunology , Lung Diseases, Fungal/surgery , Mucormycosis/surgery , Pneumonectomy , Antifungal Agents/therapeutic use , Female , Humans , Lung Diseases, Fungal/drug therapy , Lung Diseases, Fungal/immunology , Middle Aged , Mucormycosis/drug therapy , Mucormycosis/immunology , Recovery of FunctionABSTRACT
Bronchopleural fistula, one of the most serious complications following pneumonectomy, has a complicated treatment protocol and carries a high mortality rate. We present a case report of a 75-year-old female with squamous cell carcinoma of the lower lobe with positive peribronchial hilar nodes who underwent a right pneumonectomy. She represented with a large bronchopleural fistula one month postoperatively, eventually treated by a novel tracheobronchial stenting procedure.
